(Q41687574)

7 October 2017

1 reference

title

Human tumor antigens recognized by T-cells (English)

1 reference

7 October 2017

Kawakami Y

1

1 reference

7 October 2017

Rosenberg SA

series ordinal

2

1 reference

7 October 2017

publication date

1 January 1997

1 reference

7 October 2017

1 reference

7 October 2017

volume

16

1 reference

7 October 2017

issue

4

1 reference

7 October 2017

page(s)

313-339

1 reference

Tolerance, danger, and the extended family

7 October 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02786397

Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan A

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Immunization against epitopes in the human melanoma antigen gp100 following patient immunization with synthetic peptides

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Genes Coding for Tumor Antigens Recognized by Cytolytic T Lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

A peptide encoded by the human MAGE3 gene and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE3.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Cloning of a new gene encoding an antigen recognized by melanoma-specific HLA-A24-restricted tumor-infiltrating lymphocytes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Distribution of human leukocyte antigen-ABC and -D/DR antigens in the unfixed human testis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte clone recognizing a wild-type p53-derived peptide

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Vitiligo in patients with melanoma: normal tissue antigens can be targets for cancer immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

MUC‐1 Epithelial Tumor Mucin‐Based Immunity and Cancer Vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Induction of melanoma reactive T cells by stimulator cells expressing melanoma epitope-major histocompatibility complex class I fusion proteins

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Tumor-specific and HLA-A2-restricted cytolysis by tumor-associated lymphocytes in human metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Identification of a novel peptide derived from the melanocyte-specific gp100 antigen as the dominant epitope recognized by an HLA-A2.1-restricted anti-melanoma CTL line

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

p21-ras-peptide-specific T-cell responses in a patient with colorectal cancer. CD4+ and CD8+ T cells recognize a peptide corresponding to a common mutation (13Gly-->Asp).

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

The intronic region of an incompletely spliced gp100 gene transcript encodes an epitope recognized by melanoma-reactive tumor-infiltrating lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Antigen-presenting cells pulsed with unfractionated tumor-derived peptides are potent tumor vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Memory T cells of a patient with follicular thyroid carcinoma recognize peptides derived from mutated p21 ras (Gln-->Leu61).

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Generation of Human Cytotoxic T Cells Specific for Human Carcinoembryonic Antigen Epitopes From Patients Immunized With Recombinant Vaccinia-CEA Vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8+ cytotoxic-T-cell responses: evidence for immunoselection of antigen-loss variants in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Shared human melanoma antigens. Recognition by tumor-infiltrating lymphocytes in HLA-A2.1-transfected melanomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw*1601.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Identification of an HLA-A11-restricted epitope from the tandem repeat domain of the epithelial tumor antigen mucin

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Cytotoxic T cells directed to tumor antigens not expressed on normal melanocytes dominate HLA-A2.1-restricted immune repertoire to melanoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Costimulation enhances the active immunotherapy effect of recombinant anticancer vaccines.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Induction of a cytolytic T-cell response in mice with a recombinant adenovirus coding for tumor antigen P815A

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Shared epitopes for HLA-A3-restricted melanoma-reactive human CTL include a naturally processed epitope from Pmel-17/gp100.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Evidence for selection against human lung cancers bearing p53 missense mutations which occur within the HLA A*0201 peptide consensus motif

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Generation of tumor-specific cytolytic T lymphocytes from peripheral blood of cervical cancer patients by in vitro stimulation with a synthetic human papillomavirus type 16 E7 epitope

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expression.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

In vitro generation of human cytotoxic T lymphocytes specific for peptides derived from prostate-specific antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Melanoma-specific CD4+ T lymphocytes recognize human melanoma antigens processed and presented by Epstein-Barr virus-transformed B cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Development of cancer immunotherapies based on identification of the genes encoding cancer regression antigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Antigen-specific tumor vaccines. Development and characterization of recombinant adenoviruses encoding MART1 or gp100 for cancer therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Production of recombinant MART-1 proteins and specific antiMART-1 polyclonal and monoclonal antibodies: use in the characterization of the human melanoma antigen MART-1.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Human papillomavirus immunology and vaccine prospects

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

A K-ras 13Gly-->Asp mutation is recognized by HLA-DQ7 restricted T cells in a patient with colorectal cancer. Modifying effect of DQ7 on established cancers harbouring this mutation?

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

HER2/neu-derived peptides are shared antigens among human non-small cell lung cancer and ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Melanocyte lineage-specific antigens recognized by monoclonal antibodies NKI-beteb, HMB-50, and HMB-45 are encoded by a single cDNA.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Karnofsky Memorial Lecture. The immunotherapy and gene therapy of cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Retroviral transduction of human dendritic cells with a tumor-associated antigen gene.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

IL-2 enhances the function of recombinant poxvirus-based vaccines in the treatment of established pulmonary metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Identification of subdominant CTL epitopes of the GP100 melanoma-associated tumor antigen by primary in vitro immunization with peptide-pulsed dendritic cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

A survivor of breast cancer with immunity to MUC-1 mucin, and lactational mastitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Occasional memory cytotoxic T-cell responses of patients with human papillomavirus type 16-positive cervical lesions against a human leukocyte antigen-A *0201-restricted E7-encoded epitope.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

T-cell recognition of self peptides as tumor rejection antigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Expression of MUC1 on myeloma cells and induction of HLA-unrestricted CTL against MUC1 from a multiple myeloma patient

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Association of HER2/neu expression with sensitivity to tumor-specific CTL in human ovarian cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Implicating a role for immune recognition of self in tumor rejection: passive immunization against the brown locus protein

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

The next wave of recombinant and synthetic anticancer vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Induction and characterization of cytotoxic T-lymphocytes recognizing a mutated p21ras peptide presented by HLA-A*0201.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Stabilization of beta-catenin by genetic defects in melanoma cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Reactivity of autologous CD4+ T lymphocytes against human melanoma. Evidence for a shared melanoma antigen presented by HLA-DR15.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Human leukocyte antigen-A2.1 restricted candidate cytotoxic T lymphocyte epitopes of human papillomavirus type 16 E6 and E7 proteins identified by using the processing-defective human cell line T2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Tolerance to p53 by A2.1-restricted cytotoxic T lymphocytes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

CD8+ T cells from a patient with colon carcinoma, specific for a mutant p21-Ras-derived peptide (Gly13-->Asp), are cytotoxic towards a carcinoma cell line harbouring the same mutation

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

A pigmentation-associated, differentiation antigen of human melanoma defined by a precipitating antibody in human serum.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

T cell epitopes encompassing the mutational hot spot position 61 of p21 ras. Promiscuity in ras peptide binding to HLA.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

T-cell recognition of human melanoma antigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Immunoselection of a human melanoma resistant to specific lysis by autologous tumor-infiltrating lymphocytes. Possible mechanisms for immunotherapeutic failures

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residues

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Identification of epitope mimics recognized by CTL reactive to the melanoma/melanocyte-derived peptide MART-1(27-35)

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

A new gene coding for an antigen recognized by autologous cytolytic T lymphocytes on a human renal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

A phase I trial of a synthetic mucin peptide vaccine. Induction of specific immune reactivity in patients with adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Identification of a tyrosinase epitope recognized by HLA-A24-restricted, tumor-infiltrating lymphocytes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Analysis of expression of the melanoma-associated antigens MART-1 and gp100 in metastatic melanoma cell lines and in in situ lesions.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9439758

12 December 2020

Identifiers

DOI

10.1007/BF02786397

1 reference

Dimensions Publication ID

7 October 2017

1027449089

0 references

1 reference